Literature DB >> 29220754

Association of high mortality with extended-spectrum β-lactamase (ESBL) positive cultures in community acquired infections.

Sumit Ray1, Dimple Anand2, Sankalp Purwar2, Arijit Samanta2, Kaustubh V Upadhye2, Prasoon Gupta2, Debashis Dhar3.   

Abstract

PURPOSE: Infections due to multidrug resistant organisms have become a serious health concern worldwide. The present study was conducted to investigate the spectrum of microbial resistance pattern in the community and their effects on mortality.
METHODS: A retrospective review and analysis of prospectively collected data was done of all patients admitted with diagnosis of sepsis in two tertiary care ICU's for a period of two years. Demographics, culture positivity, microbial spectrum, resistance pattern and outcome data were collected.
RESULTS: Out of 5309 patients enrolled; 3822 had suspected clinical infection on admission with 1452 patients growing positive microbial cultures. Among these, 201 bacterial strains were isolated from patients who had community acquired infections. 73% were Gram negative bacilli, commonest being E. coli (63%). 63.4% E. coli and 60.7% Klebsiella isolates were ESBL producers. The mortality in ESBL positive infections was significantly higher as compared to ESBL negative infections (Odds ratio 2.756). Moreover, ESBL positive patients empirically treated with Beta Lactams+Beta Lactamase inhibitors (BL+BLI) had significantly higher mortality as compared to patients treated with carbapenems. More data from multiple centres need to be gathered to formulate appropriate antibiotic policy for critically ill patients admitted from the community.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BL+BLI; Community-acquired infections; ESBL; ESBL positive; Mortality

Mesh:

Substances:

Year:  2017        PMID: 29220754     DOI: 10.1016/j.jcrc.2017.10.036

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  10 in total

1.  Comparative Evaluation of Assays for Broad Detection of Molecular Resistance Mechanisms in Enterobacterales Isolates.

Authors:  J N Brazelton de Cardenas; C D Garner; Y Su; L Tang; R T Hayden
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

2.  In Vivo Activity of QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor, in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Mojgan Sabet; Ziad Tarazi; David C Griffith
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 3.  Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.

Authors:  Aaron Matlock; Joshua Allan Garcia; Kayvan Moussavi; Brit Long; Stephen Yuan-Tung Liang
Journal:  Intern Emerg Med       Date:  2021-05-06       Impact factor: 5.472

4.  Infections Caused by Extended-Spectrum β-Lactamase Producing Escherichia Coli in Systemic Lupus Erythematosus Patients: Prevalence, Risk Factors, and Predictive Model.

Authors:  Yuetian Yu; Hui Shen; Cheng Zhu; Ruru Guo; Yuan Gao; Liangjing Lu
Journal:  Biomed Res Int       Date:  2018-11-18       Impact factor: 3.411

5.  Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008-2017).

Authors:  C M Isgren; T Edwards; G L Pinchbeck; E Winward; E R Adams; P Norton; D Timofte; T W Maddox; P D Clegg; N J Williams
Journal:  BMC Vet Res       Date:  2019-07-29       Impact factor: 2.741

6.  Antimicrobial resistance pattern, genetic distribution of ESBL genes, biofilm-forming potential, and virulence potential of Pseudomonas aeruginosa isolated from the burn patients in Tehran Hospitals, Iran.

Authors:  Mohammad Shahbazzadeh; Elham Moazamian; Alireza Rafati; Masoud Fardin
Journal:  Pan Afr Med J       Date:  2020-07-30

7.  Effect of a Multispecies Probiotic on Intestinal and Skin Colonization by Multidrug-Resistant Gram-Negative Bacteria in Patients in a Long-Term Care Facility: A Pilot Study.

Authors:  Ines Zollner-Schwetz; Monika Scarpatetti; Gerald Pichler; Christian Pux; Ingeborg Klymiuk; Slave Trajanoski; Robert Krause
Journal:  Nutrients       Date:  2020-05-28       Impact factor: 5.717

Review 8.  Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae.

Authors:  Hayley Wilson; M Estée Török
Journal:  Microb Genom       Date:  2018-07-23

9.  Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.

Authors:  Parichehr Shamsrizi; Beryl Primrose Gladstone; Elena Carrara; Dora Luise; Andrea Cona; Chiara Bovo; Evelina Tacconelli
Journal:  BMJ Open       Date:  2020-01-20       Impact factor: 2.692

10.  Whole-Genome Sequencing of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli From Human Infections in Finland Revealed Isolates Belonging to Internationally Successful ST131-C1-M27 Subclade but Distinct From Non-human Sources.

Authors:  Paula Kurittu; Banafsheh Khakipoor; Jari Jalava; Jari Karhukorpi; Annamari Heikinheimo
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.